Parkinson's Foundation demonstrates role of genetic testing in pilot study

By staff writers

July 8, 2020 -- The Parkinson's Foundation announced the preliminary results from its Parkinson's Disease (PD) Generation: Mapping the Future of PD pilot study.

The study offered free genetic testing of clinically relevant Parkinson's-related genes and free genetic counseling to help participants better understand their results. The preliminary findings demonstrated the feasibility of conducting comprehensive genetic testing and genetic counseling for the disease and identified rare genetic mutation carriers linked to the disease.

Of the initial 291 individuals tested, 52 (around 17%) tested positive for a genetic mutation that is linked to PD. This is higher than estimates reported in the scientific literature. Moreover, the study revealed that some participants carry multiple mutations and helped identify extremely rare genetic mutations linked to the disease.

The study will continue with the goal of enrolling 15,000 participants in late 2020. The study was temporarily suspended due to the pandemic. The organization has developed a telemedicine-based approach in response to the pandemic whereby participants will be able to enroll in the study using an at-home genetic testing kit and complete virtual genetic counseling sessions.

Tau protein biomarker proves itself in Alzheimer's blood test
Swedish researchers have developed a test for Alzheimer's disease that measures a particular variant of tau protein called p-tau181 in everyday blood...
Parkinson's Foundation kicks off genetic testing program
The Parkinson's Foundation is offering free genetic testing and counseling for U.S. patients with Parkinson's disease through a partnership with Fulgent...
Cerebrospinal fluid test helps pinpoint dementia disorders
Testing for neurofilament light protein in cerebrospinal fluid appears to be helpful for differentiating some neurological conditions, such as frontotemporal...

Copyright © 2020

Last Updated ls 7/9/2020 8:31:51 AM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.